arrow_back Back to App

Support for Rare Cancer Day: Boosting Awareness and Better Treatment

This House Resolution supports designating September 30 as Rare Cancer Day. The aim is to highlight challenges faced by rare cancer patients and promote early diagnosis and effective treatment. Citizens may benefit from increased awareness and potentially improved access to diagnosis and therapies.
Key points
Designating Rare Cancer Day aims to increase public awareness of these diseases.
Emphasizes the need for early detection and development of more effective treatments for rare cancers.
Supports dedicating funding for rare cancer research, potentially leading to new therapies.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HRES_725
Sponsor: Rep. Kelly, Mike [R-PA-16]
Process start date: 2023-09-26
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expressing support for the designation of September 30, 2023, as "Rare Cancer Day" to highlight the challenges patients with rare cancers face and to raise awareness and support efforts to improve early diagnosis and treatment.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HRES_725.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-09-26.

What are the main provisions?

Key points include:

  • Designating Rare Cancer Day aims to increase public awareness of these diseases.
  • Emphasizes the need for early detection and development of more effective treatments for rare cancers.
  • Supports dedicating funding for rare cancer research, potentially leading to new therapies.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Kelly, Mike [R-PA-16].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health